568
Views
1
CrossRef citations to date
0
Altmetric
Editorial Comment

Standardized care pathway for bladder cancer in Sweden. So far lots of pain but little gain

&
Pages 233-234 | Received 11 May 2022, Accepted 13 May 2022, Published online: 23 May 2022

References

  • Abuhasanein S, Jahnson S, Aliabery F, et al. Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience. Scand J Urol. 2022;7:1–6.
  • Statistik om standardiserade vårdförlopp 2022. www.cancercentrum.se.
  • Hedelin H, Holmäng S. Vårdförloppet för blåscancer bör omvärderas. Läkartidningen. 2017;114:EFLD.
  • Holmäng S, Hedelin H. Vårdförloppet för blåscancer bör fortfarande omvärderas. Läkartidningen. 2018;115:EYXX.
  • Vasdev N, Thorpe AC. Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols? Urol Oncol. 2013;31(6):909–913.
  • Kulander O, Johansson J, Brudin L. Låg sannolikhet för cancer i urinorganen vid makroskopisk hematuri och samtidig bakteriuri. Läkartidningen. 2019;116:FHM2.
  • Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–2284.
  • Holmäng S, Hedelin H, Malmström P-U. Alltför många inkluderas i vårdförlopp urinblåsecancer. Läkartidningen. 2019;116:FIEY.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.